Status:

COMPLETED

Hypertension Detection and Follow-up Program (HDFP)

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Cardiovascular Diseases

Heart Diseases

Eligibility:

All Genders

30-69 years

Phase:

PHASE3

Brief Summary

To determine the effectiveness of systematic, sustained, antihypertensive therapy in reducing morbidity and mortality from hypertension in a wide spectrum of persons with elevated blood pressure in 14...

Detailed Description

BACKGROUND: Published data from the Veterans Administration Cooperative Study of Hypertension demonstrated that reduction in morbidity and mortality could be attained by treating men with fixed diast...

Eligibility Criteria

Men and women, ages 30-69. Hypertension. Diastolic blood pressure home readings and clinic readings equal to or above 95 mm Hg and 90 mm Hg, respectively.

Key Trial Info

Start Date :

May 1 1971

Trial Type :

INTERVENTIONAL

End Date :

May 1 1982

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00000485

Start Date

May 1 1971

End Date

May 1 1982

Last Update

July 12 2016

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Hypertension Detection and Follow-up Program (HDFP) | DecenTrialz